Satoshi Okayama Selected Research

Satoshi Okayama Research Topics

Disease

14	Heart Failure 01/2022 - 12/2009
8	Myocardial Infarction 01/2019 - 04/2006
6	Atherosclerotic Plaque (Atheroma) 01/2020 - 12/2009
5	Chronic Renal Insufficiency 10/2019 - 06/2013
5	Atherosclerosis 10/2019 - 12/2009
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2019 - 01/2006
3	Fibrosis (Cirrhosis) 11/2016 - 01/2010
3	Hypertrophy 11/2016 - 04/2010
3	Pathologic Constriction (Stenosis) 09/2015 - 01/2012
2	Acute Coronary Syndrome 01/2020 - 01/2011
2	Chronic Kidney Failure (Chronic Renal Failure) 10/2019 - 12/2012
2	Cardio-Renal Syndrome 01/2019 - 01/2013
2	Thrombosis (Thrombus) 08/2016 - 12/2009
2	Inflammation (Inflammations) 11/2015 - 01/2011
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2015 - 01/2013
2	Infarction (Infarctions) 08/2007 - 04/2006
1	Edema (Dropsy) 11/2022
1	Atrial Fibrillation 01/2022
1	Anemia 01/2021
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2020
1	Diabetes Mellitus 01/2020
1	Takotsubo Cardiomyopathy 01/2018
1	Acute Kidney Injury (Acute Renal Failure) 05/2017
1	Cardiomegaly (Heart Hypertrophy) 11/2016
1	Tricuspid Valve Insufficiency (Insufficiency, Tricuspid Valve) 06/2015
1	Coronary Stenosis (Coronary Artery Stenosis) 01/2015
1	Necrosis 01/2014
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2014
1	Stroke (Strokes) 06/2013
1	Embolism (Embolus) 01/2013
1	Dyspnea (Shortness of Breath) 12/2012
1	Lacerations 01/2012
1	Sepsis (Septicemia) 01/2011
1	Renal Insufficiency (Renal Failure) 12/2009
1	Nephrogenic Fibrosing Dermopathy 01/2009
1	Stable Angina 10/2008
1	Hyperplasia 10/2008
1	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 09/2008

Drug/Important Bio-Agent (IBA)

9	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 10/2019 - 04/2006
5	CytokinesIBA 10/2019 - 10/2008
4	Tyrosine (L-Tyrosine)FDA Link 02/2014 - 12/2009
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019 - 12/2009
3	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2019 - 04/2010
3	Biomarkers (Surrogate Marker)IBA 01/2019 - 12/2009
3	AldosteroneIBA 11/2016 - 01/2006
3	Indicators and Reagents (Reagents)IBA 01/2015 - 01/2013
2	salicylhydroxamic acid (SHAM)IBA 10/2019 - 04/2006
2	ReninIBA 01/2019 - 01/2015
2	ApolipoproteinsIBA 02/2014 - 12/2009
2	LipidsIBA 01/2012 - 01/2011
2	GadoliniumIBA 01/2011 - 01/2009
1	Creatine Kinase (Creatine Phosphokinase)IBA 11/2022
1	Hemoglobins (Hemoglobin)IBA 01/2021
1	IronIBA 01/2021
1	Docosahexaenoic AcidsIBA 01/2020
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2020
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2020
1	Eicosapentaenoic AcidIBA 01/2020
1	Insulin (Novolin)FDA Link 01/2020
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2020
1	AST 120IBA 10/2019
1	Uremic ToxinsIBA 10/2019
1	CarbonIBA 10/2019
1	omega-Chloroacetophenone (Mace)IBA 01/2019
1	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2018
1	CatecholaminesIBA 01/2018
1	GTP-Binding Proteins (G-Protein)IBA 01/2018
1	Lipocalin-2IBA 05/2017
1	SodiumIBA 11/2016
1	SaltsIBA 11/2016
1	Phenobarbital (Luminal)FDA Link 09/2015
1	DiureticsIBA 06/2015
1	Tolvaptan FDA Link 06/2015
1	Triglycerides (Triacylglycerol)IBA 01/2015
1	Serum AlbuminIBA 01/2015
1	CalciumIBA 08/2014
1	Apolipoproteins E (ApoE)IBA 02/2014
1	Heparin (Liquaemin)FDA LinkGeneric 02/2014
1	Amyloid (Amyloid Fibrils)IBA 01/2014
1	Peptides (Polypeptides)IBA 06/2013
1	Rosuvastatin Calcium (Crestor)FDA Link 01/2011
1	AcidsIBA 01/2010
1	ChloridesIBA 01/2010
1	Contrast MediaIBA 01/2009
1	MetalsIBA 10/2008
1	Sirolimus (Rapamycin)FDA Link 10/2008
1	3-Iodobenzylguanidine (Iobenguane)IBA 09/2008
1	technetium tc-99m tetrofosmin (Myoview)FDA Link 08/2007

Therapy/Procedure

6	Stents 08/2016 - 10/2008
2	Therapeutics 01/2020 - 12/2009
2	Drug-Eluting Stents 08/2016 - 12/2009
2	Renal Dialysis (Hemodialysis) 06/2013 - 12/2012
1	Catheter Ablation 01/2022
1	Patient Readmission 01/2020
1	Peritoneal Dialysis 05/2016
1	Hemodiafiltration 01/2014
1	Continuous Ambulatory Peritoneal Dialysis (CAPD) 01/2013
1	Catheters 01/2013
1	Percutaneous Coronary Intervention 01/2012
1	Transplantation 08/2007